Research Projects & Grants

Federal

• Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID), Role: Investigator, National Institute of Allergy and Infectious Diseases/NIH/DHHS, Status: Completed

For Profit Organization

• A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People >/= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection, Role: Investigator, Gilead Sciences, Inc, (07/2024 - 07/2025) Status: Approved